Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04267120 |
|---|---|
| Brief Title: | Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial) |
| First Submitted : | February 10, 2020 |
| First Submitted that Met QC Criteria : | February 10, 2020 |
| First Posted : | February 12, 2020 |
| Last Update Submitted that Met QC Criteria : | November 9, 2020 |
| Last Update Posted : | November 10, 2020 |